Daniela Huzly

Daniela Huzly

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Susceptibility of clinical isolates, laboratory-adapted and drug-resistant herpes simplex virus strains to helicase-primase inhibitor adibelivir (IM-250) and its synergy in combination therapy with acyclovir, penciclovir and foscarnet.

Susceptibility of clinical isolates, laboratory-adapted and drug-resistant herpes simplex virus strains to helicase-primase inhibitor adibelivir (IM-250) and its synergy in combination therapy with acyclovir, penciclovir and foscarnet.

Journal: Antiviral research
Published: June 09, 2026

Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Journal: Geburtshilfe und Frauenheilkunde
Published: December 16, 2025

SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient.

SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient.

Journal: Nature communications
Published: October 25, 2024

Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020.

Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: December 15, 2023

Tiza-Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study.

Tiza-Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study.

Journal: BMJ open
Published: November 02, 2023

Trends in the numbers of SARS-CoV-2 infections among students: a prospective cohort study comparing students in sports boarding schools with students in day schools during early COVID-19 pandemic.

Trends in the numbers of SARS-CoV-2 infections among students: a prospective cohort study comparing students in sports boarding schools with students in day schools during early COVID-19 pandemic.

Journal: Frontiers in public health
Published: May 16, 2023

Meningitis without Rash after Reactivation of Varicella Vaccine Strain in a 12-Year-Old Immunocompetent Boy.

Meningitis without Rash after Reactivation of Varicella Vaccine Strain in a 12-Year-Old Immunocompetent Boy.

Journal: Vaccines
Published: December 05, 2022

SARS-CoV-2 Rapid Antigen Tests for Health Care Workers.

SARS-CoV-2 Rapid Antigen Tests for Health Care Workers.

Journal: Deutsches Arzteblatt international
Published: November 09, 2022

Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.

Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.

Journal: Journal of hepatology
Published: October 25, 2022

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity.

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity.

Journal: Journal of translational medicine
Published: October 06, 2022

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation.

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation.

Journal: Vaccines
Published: September 22, 2022

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.

Journal: Nature communications
Published: July 28, 2022
Showing 1-12 of 64

Last Updated: 09/26/2026